Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: posthoc analysis. Adv Ther. 2010;27(12):941-52.Wiecek A, Ahmed I, Scigalla P, et al. Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis. Adv Ther. 2010;...
Note: Epoetin is synthesized in several forms designated alfa, beta, delta, omega, and zeta using hamster ovary cells into which the gene coding for erythropoietin has been inserted. The epoetin designated alfa is marketed under the trademarks Epogen and Procrit and the epoetin designated beta is...
The primary objective of the trial was to prove the therapeutic equivalence of epoetin zeta to epoetin alfa when administered subcutaneously for maintaining target hemoglobin (Hb) in patients with renal anemia on chronic hemodialysis. Additional information was provided on the safety and tolerability of...
To date, two epoetin biosimilars have been approved in Europe, both of which are biosimilars of Eprex®/Erypo® (International Nonproprietary Name [INN]: epoetin alfa): HX575 (INN: epoetin alfa) and SB309 (INN: epoetin zeta) (Table 1). HX575 is marketed as Binocrit® (Sandoz GmbH...
Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group (2008) Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment. Curr Med Res Opin 24:625-637...
Comparison of the therapeutic effects of epoetin zeta and epoetin alpha in the correction of renal anaemia. Curr Med Res Opin. 2008;24(5):1407-15.Krivoshiev S, Todorov VV, Manitius J, et al. Compari- son of the therapeutic effects of epoetin zeta and epoetin alfa in the correction ...
Koytchev, "Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anemia treatment," Current Medical Research & Opinion, vol. 24, no. 3, pp. 625-637, 2008.Wizemann V, Rutkowski B, Baldamus C, et al. Comparison of the therapeutic effects...
Methods: Patients received epoetin zeta or epoetin alfa intravenously, 1-3 times/week for 12 weeks, then the alternative treatment for 12 weeks, in this double-blind, crossover, phase III trial. Eligible patients were 18-75 years old with GKD stage 5 maintained on haemodialysis. Patients had...
Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment. Curr. Med. Res. Opin. 24, 625-637.Wizemann V, Rutkowski B, Baldamus C, et al. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance...
on behalf of the Epoetin Zeta Study GroupTaylor & FrancisCurrent Medical Research & OpinionKrivoshiev S, Todorov VV, Manitius J, et al. Comparison of the thera- peutic effects of epoetin zeta and epoetin alfa in the correction of renal anaemia. Curr Med Res Opin. 2008;24(5):1407-...